Research from Oxford has led to a new scan for liver disease which has been cleared for use in Europe and the USA.
Perspectum Diagnostics has announced that its LiverMultiScan imaging device, which can detect early liver disease using magnetic resonance imaging (MRI), has been given 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Rajarshi Banerjee, CEO of Perspectum Diagnostics and an honorary consultant physician in Oxford, developed the MRI method with support from the NIHR Oxford Biomedical Research Centre.
For more information click here.